Eurofins to Acquire ViraCor-IBT Laboratories - - BioPharm International

ADVERTISEMENT

Eurofins to Acquire ViraCor-IBT Laboratories



Eurofins Scientific has signed a definitive agreement to acquire ViraCor-IBT Laboratories, a provider of specialty diagnostic testing, including biologic and molecular testing, from majority owner Ampersand Capital and other shareholders for approximately $255 million, subject to post-closing adjustments.

Eurofins reports that the acquisition will strengthen both its pharmaceutical and genomic service offerings and establish a presence in the specialty clinical testing services for infectious disease, immunology, allergy, HLA, and serology. The transaction also includes retaining VIBT’s 270 employees.

Upon closing of the transaction the company will continue to be known as ViraCor-IBT Laboratories. Completion of the transaction is expected in the next 60 days.

Source: Eurofins Scientific

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines

Click here